MONROVIA, Calif.--(BUSINESS WIRE)--Xencor, Inc., a company developing protein and antibody therapeutics, today announced that it appointed David R. King as Chairman of its Board of Directors. To Xencor, Mr. King brings a rich history in the life sciences industry, most recently as a co-founder and the CEO of BioRexis Pharmaceuticals until its acquisition by Pfizer.
